Molina Healthcare (MOH) Projected to Post Earnings on Wednesday

Molina Healthcare (NYSE:MOH) is anticipated to post its quarterly earnings results after the market closes on Wednesday, April 23rd. Analysts expect Molina Healthcare to post earnings of $5.86 per share and revenue of $10.86 billion for the quarter. Molina Healthcare has set its FY 2025 guidance at 24.500- EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. On average, analysts expect Molina Healthcare to post $24 EPS for the current fiscal year and $28 EPS for the next fiscal year.

Molina Healthcare Trading Down 3.7 %

MOH stock opened at $335.57 on Wednesday. Molina Healthcare has a 1-year low of $262.32 and a 1-year high of $373.22. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69. The business’s 50 day moving average is $312.03 and its 200-day moving average is $308.21. The firm has a market cap of $18.36 billion, a P/E ratio of 16.43, a P/E/G ratio of 1.06 and a beta of 0.70.

Insider Activity

In other news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the transaction, the director now owns 17,375 shares of the company’s stock, valued at approximately $5,235,608.75. This trade represents a 5.44 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.10% of the company’s stock.

Analysts Set New Price Targets

MOH has been the topic of a number of analyst reports. Wells Fargo & Company upgraded Molina Healthcare from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $295.00 to $372.00 in a research report on Wednesday, March 5th. Barclays reduced their target price on shares of Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating on the stock in a research note on Friday, February 7th. Robert W. Baird reiterated a “neutral” rating and set a $375.00 target price (up previously from $331.00) on shares of Molina Healthcare in a research report on Tuesday. JPMorgan Chase & Co. reissued a “neutral” rating and set a $350.00 price target (down from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Finally, UBS Group decreased their price objective on shares of Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating on the stock in a research note on Friday, February 7th. Eight investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Molina Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $359.42.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.